Department of Oral Biology, University of Florida College of Dentistry , Gainesville, Florida, USA.
UF Genetics Institute , Gainesville, Florida, USA.
J Virol. 2023 Nov 30;97(11):e0138923. doi: 10.1128/jvi.01389-23. Epub 2023 Oct 27.
Kaposi's sarcoma-associated herpesvirus (KSHV) is a cancer-causing human herpesvirus that establishes a persistent infection in humans. The lytic viral cycle plays a crucial part in lifelong infection as it is involved in the viral dissemination. The master regulator of the KSHV lytic replication cycle is the viral replication and transcription activator (RTA) protein, which is necessary and sufficient to push the virus from latency into the lytic phase. Thus, the identification of host factors utilized by RTA for controlling the lytic cycle can help to find novel targets that could be used for the development of antiviral therapies against KSHV. Using a proteomics approach, we have identified a novel interaction between RTA and the cellular E3 ubiquitin ligase complex RNF20/40, which we have shown to be necessary for promoting RTA-induced KSHV lytic cycle.
卡波西肉瘤相关疱疹病毒(KSHV)是一种致癌的人类疱疹病毒,可在人类中引发持续性感染。裂解病毒周期在终身感染中起着至关重要的作用,因为它涉及病毒的传播。KSHV 裂解复制周期的主要调节因子是病毒复制和转录激活剂(RTA)蛋白,它是将病毒从潜伏状态推向裂解阶段所必需且充分的。因此,鉴定 RTA 用于控制裂解周期的宿主因子有助于寻找可用于开发针对 KSHV 的抗病毒疗法的新靶标。我们使用蛋白质组学方法鉴定了 RTA 与细胞 E3 泛素连接酶复合物 RNF20/40 之间的新相互作用,我们已经表明该相互作用对于促进 RTA 诱导的 KSHV 裂解周期是必需的。